NCT00311389已完成3 期
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 408
- 试验地点
- 1
- 主要终点
- Mean Intraocular Pressure (IOP)
研究概览
简要总结
The purpose of this study is to evaluate the intraocular pressure(IOP)-lowering efficacy of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •As specified in protocol
排除标准
- •As specified in protocol
研究组 & 干预措施
Travoprost/Timolol
Experimental
1 drop in the affected eye(s) once daily in the morning for 12 months
干预措施: Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solution (Drug)
Latanoprost/Timolol
Active Comparator
1 drop in the affected eye(s) once daily in the morning for 12 months
干预措施: Latanoprost 0.005%/Timolol 0.005% ophthalmic solution (Drug)
结局指标
主要结局
Mean Intraocular Pressure (IOP)
时间窗: 12 months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-Angle GlaucomaNCT00761709Alcon Research104
已完成
2 期
Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle GlaucomaOpen-angle GlaucomaNCT00451152Alcon Research89
已完成
2 期
A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle GlaucomaPrimary Open-Angle Glaucoma (POAG)Ocular Hypertension (OHT)NCT01917383Inotek Pharmaceuticals Corporation101
已完成
4 期
Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)Angle-closure GlaucomaNCT00762645Alcon Research30
已完成
不适用
One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma SubjectsPrimary Open Angle Glaucoma (POAG)NCT01517477Glaukos Corporation119